Skip to main content
Premium Trial:

Request an Annual Quote

Tecan Licenses Molecular Dx IP from Enigma

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tecan has licensed molecular diagnostics intellectual property from Enigma Diagnostics that it will use to pursue development of an integrated diagnostics solution with another partner.

The Swiss lab technologies developer said today that the license covers IP that is used in Enigma's automated point-of-care molecular diagnostic system, the Enigma ML.

Financial terms of the license agreement were not released.

Tecan said that the license will enable it to expand its outside equipment manufacturer business, and that the integrated solution it hopes to develop with another potential partner will provide central labs with random sample access, complete automation, a "small footprint and a rapid time to result."

"The license provides us with the opportunity to approach a potential OEM partner with our concept of an integrated solution for molecular diagnostics that includes a unique instrument as well as enabling consumables," Tecan CEO Thomas Bachmann said in a statement.

The deal follows a five-year contract the companies signed last February under which Tecan is manufacturing the Enigma ML.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.